Lee Shu-Hui, Hsueh Shun-Wen, Hung Chia-Yen, Liu Keng-Hao, Hung Yu-Shin, Chou Wen-Chi
Department of Nursing, Chang Gung Memorial Hospital at Linkou and Chang Gung University of Science and Technology, Taoyuan, Taiwan.
Division of Hema-Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital at Keelung, Keelung, Taiwan.
Support Care Cancer. 2025 May 28;33(6):507. doi: 10.1007/s00520-025-09580-w.
Older adults with cancer have a higher risk of unplanned hospitalizations, necessitating tailored interventions to improve treatment outcomes. The Eastern Cooperative Oncology Group (ECOG) performance status (PS) may overlook complex frailty deficits. Therefore, we aimed to explore whether frailty assessment enhances the prediction of unplanned hospitalizations in older adults with cancer with an excellent ECOG PS undergoing antitumor therapy.
This prospective observational study included 432 patients with cancer aged ≥ 65 years with an ECOG PS score of 0. Frailty was assessed using a geriatric assessment tool comprising eight indicators. The primary objective was to determine the proportion of patients who experienced unplanned hospitalizations within 3 months of antitumor treatment initiation. The secondary objective was to determine the length of hospital stay (LOS) among individuals who experienced unplanned hospitalizations.
Of 432 patients, 62 (14.4%) experienced unplanned hospitalizations (median LOS: 15 days, range: 2-72 days). A linear association was observed between the number of frailty deficits and the risk of unplanned hospitalizations (without frailty deficits: 7.0%; with six frailty deficits: 66.7%; R = 0.919). The median LOS steadily increased (without frailty deficits: 8 days; with six frailty deficits: 34 days; R = 0.945). Frailty assessment exhibited predictive capacity (receiver operating characteristic curve = 0.67), with a two-deficit threshold indicating a higher risk of hospitalization (9.2% versus 21.5%, relative risk: 2.72, 95% confidence interval: 1.56-4.45, p < 0.001).
Incorporating frailty assessment into clinical decision making provides valuable insights beyond ECOG PS and helps predict unplanned hospitalization risk in older adults with cancer.
老年癌症患者计划外住院风险较高,需要采取针对性干预措施以改善治疗效果。东部肿瘤协作组(ECOG)体能状态(PS)评分可能会忽略复杂的虚弱缺陷。因此,我们旨在探讨虚弱评估是否能增强对接受抗肿瘤治疗且ECOG PS评分为0的老年癌症患者计划外住院的预测能力。
这项前瞻性观察性研究纳入了432例年龄≥65岁、ECOG PS评分为0的癌症患者。使用包含八个指标的老年评估工具评估虚弱状况。主要目的是确定抗肿瘤治疗开始后3个月内发生计划外住院的患者比例。次要目的是确定发生计划外住院的患者的住院时间(LOS)。
432例患者中,62例(14.4%)发生了计划外住院(中位LOS:15天,范围:2 - 72天)。观察到虚弱缺陷数量与计划外住院风险之间存在线性关联(无虚弱缺陷:7.0%;有六个虚弱缺陷:66.7%;R = 0.919)。中位LOS稳步增加(无虚弱缺陷:8天;有六个虚弱缺陷:34天;R = 0.945)。虚弱评估显示出预测能力(受试者工作特征曲线 = 0.67),有两个缺陷的阈值表明住院风险更高(9.2%对21.5%,相对风险:2.72,95%置信区间:1.56 - 4.45,p < 0.001)。
将虚弱评估纳入临床决策可提供超越ECOG PS评分的有价值信息,并有助于预测老年癌症患者计划外住院风险。